The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat

被引:127
作者
Col, E
Caron, C
Seigneurin-Berny, D
Gracia, J
Favier, A
Khochbin, S
机构
[1] Fac Med, Inst Albert Bonniot, INSERM, U309,Lab Biol Mol & Cellulaire Differenciat, F-38706 La Tronche, France
[2] Fac Pharm, Lab Biol Stress Oxydant, F-38700 La Tronche, France
关键词
D O I
10.1074/jbc.M101385200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor acetyltransferase activity associated with several histone acetyltransferases plays a key role in the control of transcription. Here we report that hGCN5, a well known histone acetyltransferase, specifically interacts with and acetylates the human immunodeficiency virus type 1 (HIV-1) transactivator protein, Tat. The interaction between Tat and hGCN5 is direct and involves the acetyltransferase and the bromodomain regions of hGCN5, as well as a limited region of Tat encompassing the cysteine-rich domain of the protein. Tat lysines 50 and 51, target of acetylation by p300/CBP, were also found to be acetylated by hGCN5. The acetylation of these two lysines by p300/CBP has been recently shown to stimulate Tat transcriptional activity and accordingly, we have found that hGCN5 can considerably enhance Tat-dependent transcription of the HIV-1 long terminal repeat. These data highlight the importance of the acetylation of lysines 50 and 51 in the function of Tat, since different histone acetyltransferases involved in distinct signaling pathways, GCN5 and p300/CBP, converge to acetylate Tat on the same site.
引用
收藏
页码:28179 / 28184
页数:6
相关论文
共 44 条
[11]  
Herrera JE, 1999, MOL CELL BIOL, V19, P3466
[12]   Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein [J].
Hotttiger, MO ;
Nabel, GJ .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8252-8256
[13]   P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL [J].
Huang, SM ;
Qiu, Y ;
Shi, YB ;
Xu, ZX ;
Brandt, SJ .
EMBO JOURNAL, 2000, 19 (24) :6792-6803
[14]   Structure and function of a human TAFII250 double bromodomain module [J].
Jacobson, RH ;
Ladurner, AG ;
King, DS ;
Tjian, R .
SCIENCE, 2000, 288 (5470) :1422-1425
[15]   The bromodomain revisited [J].
Jeanmougin, F ;
Wurtz, JM ;
LeDouarin, B ;
Chambon, P ;
Losson, R .
TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (05) :151-153
[16]   Taking a new TAK on Tat transactivation [J].
Jones, KA .
GENES & DEVELOPMENT, 1997, 11 (20) :2593-2599
[17]   Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 tat transactivator [J].
Kamine, J ;
Elangovan, B ;
Subramanian, T ;
Coleman, D ;
Chinnadurai, G .
VIROLOGY, 1996, 216 (02) :357-366
[18]   Tackling Tat [J].
Karn, J .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (02) :235-254
[19]   HIV-1 Tat transcriptional activity is regulated by acetylation [J].
Kiernan, RE ;
Vanhulle, C ;
Schiltz, L ;
Adam, E ;
Xiao, H ;
Maudoux, F ;
Calomme, C ;
Burny, A ;
Nakatani, Y ;
Jeang, KT ;
Benkirane, M ;
Van Lint, C .
EMBO JOURNAL, 1999, 18 (21) :6106-6118
[20]   Nearly optimum multilevel block truncation coding based on a mean absolute error criterion [J].
Kuo, CH ;
Chen, CF .
IEEE SIGNAL PROCESSING LETTERS, 1996, 3 (09) :269-271